# Transcriptomic signatures in tetrapartite brain region identifies shared and unique gene signatures for substance-use

**Authors:** Avinash Veerappa, Chittibabu Guda

PMC · DOI: 10.3389/fncel.2026.1770214 · Frontiers in Cellular Neuroscience · 2026-03-18

## TL;DR

This study identifies unique and shared gene patterns in four brain regions linked to substance use, revealing how chronic use disrupts brain signaling and contributes to addiction.

## Contribution

The study reveals novel gene signatures and biomarkers for addiction by analyzing shared and unique transcriptomic patterns across four brain regions.

## Key findings

- Distinct gene signatures were identified in the midbrain, DLPFC, NAc, and amygdala of substance users.
- Upregulated genes across all regions are linked to the CREB Signaling in Neurons pathway, indicating long-term neurocircuitry changes.
- Network analysis shows disrupted neuropeptide-neurotransmitter balance due to substance use.

## Abstract

Chronic substance use is a neuropsychiatric disorder marked by persistent craving, reward seeking, and progression to addiction. The midbrain governs hunger, reward, and pleasure; the DLPFC modulates craving, decision making, and tolerance; the NAc influences feeding, reward, stress, and drug self-administration; and the amygdala regulates emotion and memory.

To understand these complex and dynamic events in the context of substance use disorders, we profiled transcriptomes from these four regions and integrated clustering, biclustering, WGCNA, and pathway enrichment analyses.

Upregulation of gene expression was dominant in all four brain regions of cases versus controls. Distinct differential transcriptomic signatures were both unique to individual regions and shared across regions, identifying 186 genes exclusive to midbrain, 29 to DLPFC, 160 to NAc, and 442 in amygdala. Network analysis revealed DEGs across all regions interconnected via a neuropeptide-neurotransmitter axis, suggesting substances disrupt the equilibrium between neurotransmitters and neuropeptides. Significant upregulation of CSF3, GADD45B, SOCS3, and NPAS4 across all four regions enriched the CREB Signaling in Neurons pathway, supporting their involvement in long-lasting maladaptations of neurocircuitry due to chronic substance use.

By unraveling unique and shared transcriptomic signatures, our study advances understanding of crosstalk among key players in each brain region in substance use, implying that induction and exclusion signals drive distinct pathway signaling and sustain addiction behavior. Alongside known genes in substance biology and addiction, we also identified several novel biomarkers that could confer susceptibility for addiction risk.

## Linked entities

- **Genes:** CSF3 (colony stimulating factor 3) [NCBI Gene 1440], GADD45B (growth arrest and DNA damage inducible beta) [NCBI Gene 4616], SOCS3 (suppressor of cytokine signaling 3) [NCBI Gene 9021], NPAS4 (neuronal PAS domain protein 4) [NCBI Gene 266743]

## Full-text entities

- **Genes:** CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, SOCS3 (suppressor of cytokine signaling 3) [NCBI Gene 9021] {aka ATOD4, CIS3, Cish3, SOCS-3, SSI-3, SSI3}, NPAS4 (neuronal PAS domain protein 4) [NCBI Gene 266743] {aka Le-PAS, NXF, PASD10, bHLHe79}, GADD45B (growth arrest and DNA damage inducible beta) [NCBI Gene 4616] {aka GADD45BETA, MYD118}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}
- **Diseases:** addiction (MESH:D019966), neuropsychiatric disorder (MESH:D001523)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13038532/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13038532/full.md

## References

129 references — full list in the complete paper: https://tomesphere.com/paper/PMC13038532/full.md

---
Source: https://tomesphere.com/paper/PMC13038532